RUNX1 Research Program – Mark Foundation for Cancer Research STRIVE Grant Program

The Mark Foundation for Cancer Research and the RUNX1 Research Program have partnered to support innovative studies that aim to delineate the role of inflammation, the immune system and clonal evolution from CHIP to clonal hematopoiesis of oncogenic potential (CHOP) to overt

malignancy in RUNX1-FPD. All proposed projects must be oriented towards developing novel cancer prevention interventions for RUNX1-FPD.

 

 

Funding: $250,000 total 

Duration: 12-18 months

 

 

 

Research Authority due date: 1.2.21

LOI (required) due date: 8.2.21

Full proposal due date: 26.4.21